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Abstract
Background: Kyasanur Forest disease virus (KFDV) and Alkhurma hemorrhagic fever virus (AHFV) are closely related
members of the Flavivirus genus and are important causes of human disease in India and the Arabian Peninsula,
respectively. Despite high genetic similarity, the viruses have distinctly different host ranges and ecologies. Human cases of
KFDV or AHFV develop a spectrum of disease syndromes ranging from liver pathology to neurologic disease. Case reports
suggest KFDV is more commonly associated with hepatic and gastrointestinal manifestations whereas AHFV is more
commonly associated with neurologic disease.
Methodology/Principal Findings: Inoculation of three immunocompetent laboratory mouse strains revealed that KFDV was
consistently more lethal than AHFV. In subsequent studies utilizing C57BL/6J mice, we demonstrated that KFDV infection
was associated with higher viral loads and significantly higher mortality. KFDV-infected mice rapidly developed more severe
disease than AHFV-infected mice, as evidenced by significant abnormalities on clinical chemistry panels and more severe
pathology in the brain and gastrointestinal tract.
Conclusions/Significance: Infections of C57BL/6J mice with KFDV or AHFV resulted in clinical disease syndromes that
closely approximate the diseases seen in human cases. Despite high genetic similarity, there were clear differences in
survival, viral kinetics, clinical chemistry data and histology. These results suggest that distinct mouse models for AHFV and
KFDV are necessary in order to gain a better understanding of the unique pathogenesis of each virus, as well as to provide
platforms for testing promising vaccines and therapeutics.
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Introduction
Alkhurma hemorrhagic fever virus (AHFV) and Kyasanur
Forest disease virus (KFDV) are closely related members of the
genus Flavivirus [family Flaviviridae]. The genus is subdivided by
vector into three groups: mosquito-borne, tick-borne, and a group
including flaviviruses with no known vector. Several tick-borne
flaviviruses (AHFV, KFDV, Omsk hemorrhagic fever virus
(OHFV), Powassan virus, and tick-borne encephalitis virus), as
well as a number of mosquito-borne flaviviruses (West Nile virus,
Dengue virus, Yellow fever virus, Japanese encephalitis virus, etc.)
are important human pathogens.
The closely related AHFV and KFDV cause similar disease
syndromes in people, marked by sudden onset fever, myalgia and
arthralgia. In severe cases, sequelae can include encephalitis and/
or a hemorrhagic syndrome, with the latter defined by petechiae,
epistaxis, bleeding from gums, hematemesis, melena and hema-
tochezia [1–5]. Most commonly in AHFV cases, neurologic
clinical signs have been described, including tremors, seizures,
neck rigidity, confusion, convulsions or coma [1–5]. In contrast, a
review of fatal human cases of KFDV suggested that gastrointes-
tinal hemorrhage is the most common finding [4]. The overall case
fatality of KFDV infection is estimated to be 1–2% of the 400–500
cases reported annually, and a recent outbreak suggested AHFV
mortality is similar to KFDV (,2%) [2]. Previously, reports of
AHFV were associated with a higher case fatality ratio of 25% [5]
that indicated a failure to identify asymptomatic or mild cases
initially. More recently, the number of human AHFV infections
documented annually is generally less than 100 [6]. Beyond
supportive care, there is no specific treatment for either AHFV or
KFDV infection.
Despite their high genetic similarity (.92% by nucleotide) and
the similar clinical syndromes they cause in humans, AHFV and
KFDV diverged more than 700 years ago [7] and have since
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maintained distinct geographic ranges, primarily in Saudi Arabia
and India, respectively. However, the viruses were only first
identified during the second half of the 20th century. In 1957,
KFDV was recognized as the cause of human disease in the
Shimoga district of India and concurrent massive deaths of
nonhuman primates in the Kyasanur Forest. KFDV human cases
remain isolated to regions within Karnataka State. Almost 40
years later in 1994, AHFV was isolated from a fatally infected
butcher in Makkah, Saudi Arabia. Since then, AHFV cases have
been confirmed in Jeddah, Jizan, and Najran in Saudi Arabia and
most recently across the Red Sea, near the Egypt-Sudan border in
2010 [8].
Risk factors associated with KFDV infection include activities in
the Kyasanur Forest region, handling ill or dead primates,
exposure to ticks (primarily Haemaphysalis spp), or through
laboratory infections [1]. Human AHFV infections have also
been associated with tick bites, and AHFV has been isolated from
an Ornithodoros tick in Jeddah [9], and Ornithodoros savignyi and
Hyalomma dromedarii ticks in Najran [10]. However, another
common risk factor for AHFV infection appears to be close
contact with domestic animals, particularly sheep and camels [3],
although no disease has been reported in these animals.
A KFDV vaccine is available, however, the efficacy of this
vaccine is unclear [1], and hundreds of human KFDV cases
reported every year. Recently, an upsurge of cases in 2012 has
been attributed to a shortage of this vaccine and the subsequent
failure to provide booster vaccinations to individuals at high risk
[11]. The increasing number of KFDV cases, coupled with AHFV
range expansion into east Africa, highlights the need for efficacious
vaccines and development of antiviral drugs. Here we describe the
development of lethal disease models of KFDV and AHFV
infection for this purpose. Previously, KFDV infection was
described in several species, including laboratory rodents and
wild animals (reviewed in [12]). However, this work describes the
first model of AHFV infection in the mouse model, and therefore
provides the first opportunity to directly compare the relative
pathogenesis of these genomically similar, yet ecologically distinct
viruses.
Materials and Methods
Ethics statement
Animal procedures in this study complied with institutional
guidelines, the US Department of Agriculture Animal Welfare
Act, and the National Institutes of Health Guide for the Care and
Use of Laboratory Animals. All procedures were approved by the
Centers for Disease Control and Prevention (CDC) Institutional
Animal Care and Use Committee (IACUC).
Biosafety
All work with infectious KFDV and AHFV was completed in a
biosafety level (BSL)-4 laboratory at the Centers for Disease
Control and Prevention (CDC, Atlanta, GA, USA). All animals
were housed within the BSL-4 laboratories in microisolator pans
in HEPA filtration racks, following standard barrier techniques.
All laboratorians and animal handlers adhered to international
biosafety practices appropriate for BSL-4, strictly following
infection control practices to prevent cross-contamination between
individual animals.
Animals and husbandry
Female 6–8 week old C3H, A/J and C57BL/6J mice were
obtained from a commercial vendor (Jackson Laboratory). Mice
were housed in groups of 5, and supplied a commercially available
mouse chow and water ad libitum. After infection, each animal was
observed a minimum of once per day, and its health assessed and
scored by experienced CDC veterinarians or animal health
technicians. Animals were euthanized if found in acute distress
or moribund, or if they scored greater than 10 on a pre-
determined clinical illness scoring algorithm: (2 points) hunched
posture, ruffled coat or huddling; (3 points) ataxia, circling, paresis,
or tremors; (5 points) apparent anemia (pale mucous membranes),
or difficulty breathing.
Viruses
KFDV strain P9605 was originally isolated in 1957 from serum
of a human patient in Shigga, Karnataka. Wild-type KFDV (strain
P9605) and AHFV (strain 200300001) were grown from stocks in
the CDC Viral Special Pathogens Branch reference collection.
Viruses were propagated in VeroE6 cells with Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 5% fetal bovine
serum (FBS) and penicillin-streptomycin (Invitrogen). Titers of all
viral stocks were determined as tissue culture infective dose 50
(TCID50) on VeroE6 cells and visualized by indirect fluorescent-
antibody assay (IFA) using anti-KFDV hyperimmune mouse
ascitic fluid (HMAF) primary antibody.
Animal infections
In the first animal experiment, inbred mouse strains were
evaluated for use as pathogenesis models of KFDV and AHFV
infections. Three common immunocompetent laboratory mouse
strains (C3H, C57BL/6J, and A/J) were inoculated in groups of 10
with either 1.06105 TCID50 KFDV or 1.0610
5 AHFV TCID50
subcutaneously (sc) in a volume of 100 mL sterile DMEM. Mock-
infected controls were inoculated with 100 mL sterile DMEM.
Animals were evaluated twice daily for 28 days following infection.
In a follow-up experiment, a 50% lethal dose (LD50) study was
undertaken to determine the dose of virus required to cause
mortality in 50% of infected C57BL/6J mice. All mice were
implanted with an identification chip for noninvasive measure-
ment of body temperature. Mice in groups of 5 were infected sc
with AHFV or KFDV at the following doses: 100,000; 10,000;
1,000; 100; 10; or 1 TCID50.
A serial euthanasia study was next undertaken utilizing the
C57BL/6J mouse model to compare the kinetics of viral spread,
clinical parameters of disease progression, innate immune
response and virus-associated pathology of mice infected with
16105 TCID50 of AHFV or 1610
5 TCID50 KFDV. On 1, 4, 6,
and 7 days post-infection (dpi), 5 AHFV- and 5 KFDV-infected
mice were anesthetized with isofluorane, terminally bled and
perfused with PBS. Whole blood was taken for complete blood
counts (CBC) and a metabolic blood chemistry panel. Samples of
liver, spleen, kidney, gastrointestinal tract (GIT) and brain were
taken for quantitation of virus load and histology.
Hematological parameters
Whole blood was collected under general anesthesia by
intracardiac puncture into either EDTA-coated or heparin-coated
vacutainer tubes. CBCs were performed using the Hematrue
blood analyzer (HESKA). Blood chemistry profiles were obtained
from heparinized whole blood samples using the Piccolo point of
care chemistry analyzer (Abaxis).
Total RNA extraction
Liver, spleen, kidney, GIT, brain and blood specimens were
collected on days 1, 4, 6 and 7 post-infection, and from animals
reaching experimental end points. RNA was extracted using
KFDV Is More Lethal than AHFV in the Mouse Model
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MagMax Total RNA Isolation kit (Ambion). Approximately
100 mg tissue samples were placed directly in lysis buffer and
homogenized using a high throughput tissue grinder (GenoGrin-
der2000). Homogenates were extracted using the MagMax
Express-96 Magnetic Particle Processor (Ambion) according to
manufacturer’s directions including a DNase treatment step.
Approximately 50 mL of whole blood was added directly to lysis
buffer with isopropanol and extracted using the MagMax Express-
24 Magnetic Particle Processor (Ambion) following manufacturer’s
protocol.
Quantitative reverse-transcription PCR (qRT-PCR) for viral
RNA quantification
AHFV and KFDV RNA were detected using primers and probe
targeting a conserved region of the NS3 protein (forward primer: 59-
ATGAGTGAGGAAAGGGCCAT-39; reverse primer: 59-CTCA-
TACTCTGTTATCCAGTC-39; probe: 59-6FAM-ACGGAGA-
GTGGAGAGAAGGCTT-39). For each viral genome detection
reaction, 2.5 mL of total RNA (approximately 0.5 mg RNA) was
added to a one-step qRT-PCR reaction (SuperScript III
Platinum One-Step qRT-PCR kit, Invitrogen) and run using
the ABI 7500 or Viia7 Real-Time PCR systems (Applied
Biosystems). RNA genome equivalents in infected blood and
tissue specimens were obtained using standard curves generated
by serial dilutions of the same known-titer stocks of AHFV and
KFDV used for infection. The results of all qRT-PCR runs
were normalized to endogenous mouse-specific controls (glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH), Invitrogen)
following the manufacturer’s recommended protocols to account
for sample-to-sample variation.
Antiviral assays
Mouse antiviral Response quantitative PCR arrays (Qiagen
SAMM-122Z) were used to determine relative gene expression of
a select panel of 84 antiviral genes in mice infected with AHFV or
KFDV, relative to mock infected mice. Assays were run on brain
samples from 3 AHFV-infected mice, 3 KFDV-infected mice, and
3 mock-infected mice euthanized on 1 and 4 dpi. For each sample,
cDNA was synthesized from 0.8–1.0 mg of RNA using the RT2
first strand kit (SABioscience). Arrays were run on an ABI 7500
using RT2 SYBR Green/ROX PCR master mix according to
manufacturer’s instructions (SABioscience).
Histology
At the time of collection, liver, spleen, brain, intestine, and
kidney tissue specimens were fixed by immersion in 10% neutral
buffered formalin for 7 days and gamma-irradiated (2.06106
RAD) prior to processing. Tissues were paraffin-embedded
following routine methods, sectioned at approximately 4 micro-
meters, and stained with hematoxylin and eosin (H&E) for
histological examination.
Statistical analyses
All analyses were completed using the PRISM v5.0 program
(Graphpad). For each mouse strain, differences between AHFV
and KFDV survivor curves were evaluated using the Log-rank
(Mantel-Cox) test. Potentially significant differences between
AHFV and KFDV viral loads in tissues were evaluated using a
two-way ANOVA with Bonferroni post-tests for multiple com-
parisons. For the complete blood counts and clinical chemistry
data, significant differences between infected and sham-infected
animals at each time point were analyzed using a one-way analysis
of variance (ANOVA) with Dunnett’s adjustment for multiple
comparisons (*p,0.05; **p,0.01, ***p,0.001). For the antiviral
array analysis, the mean value for each gene was calculated from
replicate tissue samples using the threshold cycle (CT) method and
normalized to the average values for five housekeeping genes (Gus-
b, Hprt, HSP-90AB1, GAPDH, and b-actin genes). The P values
were calculated using Student’s t test (SABioscience) for each gene
in the AHFV and KFDV-infected groups.
Results
KFDV is more virulent than AHFV in 3 inbred mouse
strains
Three common laboratory mouse strains were infected via the
subcutaneous route with either 105 TCID50 KFDV or 10
5
TCID50 AHFV sc. KFDV-infected mice displayed signs of
progressive illness including hunched posture, ruffled fur and
lethargy starting 6 dpi with tremors developing in some mice prior
to death. Onset of similar clinical disease occurred later in AHFV-
infected mice, beginning on 9 dpi, with indications of neurologic
disease including hind-limb paralysis, ataxia and/or tremors. At
no point during the course of infection did KFDV- or AHFV-
infected mice become febrile; in both groups, body temperature
did not significantly differ from mock-infected mice. Mortality was
significantly higher in all mice infected with KFDV relative to
AHFV, regardless of strain: C57BL/6: 100% vs. 50% (p,0.0001),
C3H: 90% vs. 60% (p,0.05), A/J 100% vs. 10% (p,0.0001)
(Figure 1). In the subsequent LD50 assay in C57BL/6J mice, the
LD50 of KFDV (,1 TCID50) was significantly lower than that of
AHFV (.105 TCID50) (Table 1).
Peak viral RNA loads were found in the tissues of KFDV-
infected mice earlier than AHFV-infected C57BL/6J mice
KFDV-infected mice had higher viremia 1 day post-infection
(dpi), but blood from AHFV-infected mice had vRNA present
through 7 dpi (Figure 2A). The highest vRNA titers in the spleens
were found 1 dpi, suggesting the spleen is an early site for virus
amplification for both viruses (Figure 2B). Very low amounts of
vRNA were found in the liver and kidney of mice in both groups
throughout the course of infection (data not shown). KFDV-
infected mice had high vRNA loads in the gastrointestinal tract
(Figure 2C) and brain (Figure 2D) beginning 4 dpi. Two days
later, AHFV levels in the GIT were equivalent to those of KFDV-
infected mice. However, the brains of KFDV-infected mice had
significantly higher vRNA loads than AHFV-infected until 7 dpi.
Figure 1. KFDV is more virulent than AHFV in 3 immunocom-
petent mouse strains. C3H, A/J and C57BL/6J mice were inoculated
subcutaneously with either 16105 TCID50 AHFV or 1610
5 TCID50 KFDV
(n = 10/group) and monitored for 28 days. Regardless of strain, KFDV
infection resulted in higher mortality and more severe disease than
AHFV.
doi:10.1371/journal.pone.0100301.g001
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KFDV- and AHFV-infected mice developed transient
lymphopenia
CBC data indicated that both AHFV- and KFDV-infected mice
developed marked lymphopenia that was significant 1 dpi
(Figure 3B). By 6 dpi, mice in both groups had significant
monocytosis (Figure 3C) and neutrophilia (Figure 3D). There were
no other alterations in the CBC data, and no significant differences
between KFDV- and AHFV-infected mice.
KFDV-infected mice, but not AHFV-infected mice,
developed elevated liver enzymes, azotemia,
hypoalbuminemia and hypoglycemia late in infection
Chemistry data from KFDV-infected mice indicated significant
deviations from normal values. KFDV-infected mice had in-
creased blood-urea nitrogen (BUN) 7 dpi (Figure 4A) and normal
creatinine (Figure 4B), driving an increased BUN/creatinine ratio.
Liver enzymes were elevated in KFDV-infected mice: ALT on 1
and 7 dpi (Figure 4C), and AST from 4 dpi through the end of the
infection (Figure 4D). During the late stages of the disease,
Table 1. Survival data for C57BL/6 mice following infection with KFDV or AHFV sc.
Dose (TCID50) 1 10 100 1000 10000 100000
KFDV 2/5 0/5 0/5 0/5 0/5 0/5
AHFV 5/5 5/5 4/5 5/5 5/5 3/5
Values indicate the number of mice (out of 5) that survived infection with KFDV or AHFV as of 30 dpi.
doi:10.1371/journal.pone.0100301.t001
Figure 2. KFDV-infected mice have higher viral RNA loads than AHFV-infected mice early in infection. Viral RNA loads in the (A) blood,
(B) spleen, (C) gastrointestinal tract and (D) brain were compared between KFDV- and AHFV-infected mice on 1, 4, 6 and 7 dpi. Asterisks indicate
significant differences between KFDV- and AHFV-infected mice (n = 5; p,0.05). The gray dotted line denotes limit of detection of the assay.
doi:10.1371/journal.pone.0100301.g002
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hypoalbuminemia (Figure 4E) and hypoglycemia (Figure 4F) were
apparent in KFDV mice. In contrast, all chemistry values from
AHFV-infected mice were indistinguishable from mock-infected
mice.
Antiviral gene expression was elevated in brains of AHFV-
and KFDV-infected mice
In order to address the possibility that the higher viral loads and
more rapid virus dissemination in KFDV-infected mice relative to
AHFV-infected mice were due to reduced antiviral immune
responses, we compared antiviral gene expression between groups.
We focused on the immune response in the CNS because it is a
major target of viral infection, and KFDV-infected mice had viral
RNA present in the CNS earlier and at higher levels than AHFV-
infected mice. We therefore compared the interferon-stimulated
responses in the brains of mice 1 and 4 dpi, before virus-mediated
pathology was apparent in the brain. Relative to mock-infected
mice, both groups of infected mice demonstrated significant
upregulation of interferon stimulated genes (ISGs) including IRF7,
ISG15, Mx1, OAS and STAT1 on 1 and 4 dpi (Figure 5A).
AHFV- and KFDV-infected mice also had significant upregula-
tion of dsRNA sensors, including the cytosolic helicases RIG-I,
MDA5 and LGP2, as well as TLR3 (Figure 5B). There were no
significant differences in antiviral gene expression between AHFV-
and KFDV-infected mice.
Histopathologic lesions occurred earlier and were more
severe in KFDV-infected mice than in AHFV-infected mice
The earliest histopathologic lesions consisted of multifocal
splenic fibrin thrombi at 1 dpi in three of five KFDV-infected
mice. No other splenic lesions were identified in any virus- or
mock-infected mice on any day. Early brain lesions consisted of
very mild perivascular cuffing in one of five KFDV-infected mice
at 4 dpi. By 6 and 7 dpi, all KFDV-infected mice exhibited
moderate to severe meningoencephalitis with lymphocytic and
histiocytic perivascular cuffing, acute neuronal necrosis, micro-
Figure 3. KFDV and AHFV-infected mice developed significant lymphopenia relative to control mice. Complete blood counts were run
on KFDV-, AHFV- and mock-infected mice on 1, 4, 6, and 7 dpi. (A) Leukocyte, (B) lymphocyte, (C) monocyte and (D) granulocyte counts are displayed.
Asterisks indicate significant differences between KFDV-infected mice (blue) or AHFV-infected mice (green) relative to mock-infected animals (p,
0.05). On each day, data was collected from a minimum of 3 and a maximum of 5 mice per group.
doi:10.1371/journal.pone.0100301.g003
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gliosis, and glial nodules (Figure 6A and 6B). Areas of gliosis and
perivascular cuffs sometimes also contained neutrophilic infiltrate
and karyorrhectic cell debris. Lesions were most consistently
present in the cerebral cortex, thalamus, midbrain, and brainstem,
but the olfactory bulb, hippocampus, and cerebellum were also
variably involved. Brain lesions in AHFV-infected mice were
milder, affected fewer individuals, and were delayed in onset
compared to KFDV-infected mice. Mild meningitis and perivas-
cular cuffing first appeared at 6 dpi in only one of five AHFV mice
(Figure 6C). At 7 dpi, one of five AHFV-infected mice had
meningoencephalitis of similar character and severity to lesions in
6–7 dpi KFDV-infected mice, while two mice exhibited only mild
perivascular cuffing and two remained unaffected.
Small intestine was available for histologic examination in both
infected groups from 6 and 7 dpi, and from mock-inoculated mice.
Small intestinal lesions were most significant in KFDV-infected
mice, and consisted of histiocytic, lymphocytic, and variably
neutrophilic infiltrate in the submucosa and muscularis. This
inflammation often involved, obscured, and disrupted submucosal
and myenteric nerve plexi (Figure 6E; normal plexi for compar-
ison, mock-infected mice, Figure 6D). KFDV-infected mice also
had evidence of an acute, necrotizing process characterized by
intestinal crypt dilation and necrosis, and accumulation of
abundant cell debris in the intestinal lumen (Figure 6F). Enteritis
in AHFV-infected mice was less severe than that in KFDV mice,
and consisted only of mixed inflammation in the submucosa and
muscularis. Lesions were minimal at 6 dpi and mild at 7 dpi,
affecting 3 and 5 mice, respectively. As in KFDV mice,
inflammation sometimes centered on submucosal and myenteric
plexi. In the liver of KDFV-infected mice, there was mild
microvesicular hepatocellular vacuolation (lipidosis, consistent
with inanition) on days 6 and 7. No significant lesions were
identified in kidneys from any group, or in any tissues from mock-
infected mice.
Discussion
Tickborne flaviviruses, including OHFV, TBEV, AHFV and
KFDV, are important human pathogens in certain regions of the
world. AHFV was identified almost 40 years after the initial
description of KFDV, and the remarkable genetic similarity led to
the initial classification of AHFV as a subtype of KFDV. However,
their different geographic ranges, ecologies, and recent phyloge-
netic analyses suggest that these viruses diverged hundreds of years
ago [2,7]. AHFV, found originally in Saudi Arabia, has since been
found repeatedly in Egypt in close association with camel markets
[5,13]. In contrast, all the known KFDV cases occur with a small
region surrounding the Kyasanur Forest in southwest India. Given
these apparent differences in ecology, public health impact and
host range we evaluated the viruses for differences in clinical
disease and mortality, viral kinetics, clinical parameters and
pathology in mice.
In an initial study, three commonly used laboratory mouse
strains were tested for susceptibility to KFDV and AHFV.
C57BL/6, C3H and A/J mice are all commonly used and
immunocompetent mouse strains; they differ immunologically in
Figure 4. KFDV infection and not AHFV infection resulted in significant biochemical changes, particularly at late time-points post-
infection. KFDV infection was associated with (A) elevated BUN, (B) slightly increased creatinine, (C) elevated ALT, (D) elevated AST, (E)
hypoalbuminemia and (F) hypoglycemia. Asterisks indicate significant differences between KFDV-infected mice (blue) relative to mock-infected
animals (p,0.05). No alterations in clinical chemistry values were significant in AHFV-infected mice (green). On each day, data was collected from a
minimum of 3 and a maximum of 5 mice per group.
doi:10.1371/journal.pone.0100301.g004
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their MHC H2 haplotypes. In all three strains, KFDV infections
resulted in a more rapid and severe disease than seen with AHFV-
infected mice. Of the mice infected with KFDV, 90–100%
succumbed to infection, as compared 10–50% mortality seen
following AHFV infection. It is important to note that mice
infected with KFDV or AHFV received the same dose of virus,
despite the differences in LD50 between groups, in order to
directly compare gross differences in pathogenesis between the two
viruses. Future studies to compare more subtle differences in
pathogenesis might provide valuable information by utilizing virus
doses with equivalent LD50s.
KFDV and AHFV have much lower case fatality rates in
humans, however, clinical disease in the mouse models, and
particularly the C57BL/6 mice, were strikingly similar to case
reports of severe human disease. KFDV-infected mice consistently
demonstrated gross anatomical signs of gastrointestinal hemor-
rhage, which correlates with the primary autopsy findings in a
broad evaluation of 100 human KFDV cases [4,6]. AHFV-
infected mice had clinical indications of neurologic disease,
including partial paralysis and tremors, as has been described in
AHFV human infections [2,3,7]. KFDV and AHFV disease in the
mouse model differed from published descriptions of human
disease; mice did not become febrile or develop overt symptoms of
biphasic or delayed-onset disease.
Both AHFV and KFDV patients have consistently been
described as having CBC abnormalities including lymphopenia
[1,2,4,8,14–16], as was seen in KFDV- and AHFV-infected mice.
Transient lymphopenia is a common finding following viral
infection and has been shown to be associated with an early Type I
interferon response [17]. Reports of both KFDV and AHFV
human cases have described significant hypoalbuminemia, elevat-
ed blood urea nitrogen (BUN) and liver transaminases [4,5,9,18].
In the mouse model, KFDV-infected mice, but not AHFV-
infected mice had values significantly greater than mock-infected
Figure 5. KFDV- and AHFV-infected mice mount an early innate
response to infection in the CNS. In the brains of mice infected with
KFDV or AHFV, there was significant upregulation of (A) interferon-
stimulated genes and (B) pathogen recognition receptors (PRRs). There
were not significant differences in gene expression between mice
infected with AHFV and those infected with KFDV (n = 5; p.0.05).
doi:10.1371/journal.pone.0100301.g005
Figure 6. More severe histopathologic lesions were apparent in
the brains and gastrointestinal tracts of KFDV-infected mice
than AHFV-infected mice. (A) Brain, hippocampus, KFDV-infected
mouse, 6 dpi; acute necrosis and loss of hippocampal neurons
(segment delineated by arrowheads), with adjacent, relatively unaffect-
ed neurons (arrow). (B) Brainstem, KFDV-infected mouse, 6 dpi; severe
meningoencephalitis with perivascular cuffing (arrow) and widespread
gliosis in the adjacent neuropil (asterisk). (C) Brainstem, AHFV-infected
mouse, 7 dpi; mild meningoencephalitis characterized by perivascular
cuffing (arrows). (D) Small intestine, mock-inoculated mouse; normal
tissue section demonstrating anatomic location of submucosal (arrow)
and myenteric (arrowhead) nerve plexi and normal intestinal villi; inset
shows higher magnification of neuron cell bodies in plexus. (E) Small
intestine, KFDV-infected mouse, 7 dpi; moderate, predominantly
histiocytic, inflammatory infiltrate in submucosa and muscularis,
involving and disrupting myenteric plexi (arrowheads). Inset shows
higher magnification of infiltrate and cell debris in plexus. (F) Small
intestine, KFDV-infected mouse, 7 dpi; intestinal crypts are dilated and
filled with necrotic cells (asterisks), intestinal lumen contains abundant
cellular debris (top of image), and villi are blunted and fused. All H&E
images, original magnification 200x.
doi:10.1371/journal.pone.0100301.g006
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mice, which may explain the more rapid and severe course of
disease in KFDV infection.
KFDV-infected mice succumbed to infection within 7–9 days.
Hypoglycemia and presumptive lipidosis in these mice suggest
anorexia as a prelude to the development of clinical disease. In
contrast, approximately one-half of AHFV-infected mice devel-
oped fatal disease between 9 and 15 dpi characterized by signs of
neurologic involvement, while the remaining half survived with no
indication of clinical signs. In both groups, rapid viral dissemina-
tion to the spleen occurs within 24 hours after infection, although
viral loads in AHFV-infected mice were one log lower than
KFDV-infected mice. High levels of virus replication and
associated evidence of progressive mild to moderate meningoen-
cephalitis was evident as early as 4–6 dpi in KFDV-infected mice
but lagged by 2–3 days in AHFV-infected mice. Viral replication
was apparent in the small intestine of KFDV-infected mice at the
same time, and by 6 dpi, there was histologic evidence of an acute
necrotizing process. Significant elevation in BUN of KFDV-
infected mice and an elevated BUN/creatinine ratio, coupled with
the hypoalbuminemia, are consistent with GI hemorrhage. AHFV
loads were significantly lower in the GIT through 6 dpi, with
minimal enteritis evident and there were no abnormalities in the
clinical chemistry data indicative of GI hemorrhage. In both
KFDV- and AHFV-infected mice, intestinal lesions included
inflammation of enteric nerve plexi, associated with neuronal
degeneration and depletion. This finding has also been reported in
mouse models of West Nile virus [10,19].
Both viruses stimulated increased antiviral gene expression
relative to mock-infected control mice and there were no
significant differences between AHFV and KFDV in any of the
86 antiviral genes evaluated. These results suggested that the
viruses stimulate similar responses in the CNS by triggering a type
I interferon response as evidenced by upregulation of interferon-
stimulated genes Mx1, OAS, ISG15, IRF7 and STAT1. Increased
expression of RIG-I and MDA5 suggested that AHFV and KFDV
could be recognized by one or both of the cytosolic helicases, as
has been demonstrated for JEV, WNV, DENV and possibly YFV
(reviewed in [3,20]). Similarly, upregulation of TLR3 suggests that
dsRNA replication intermediates might be recognized in the
endosome as has been postulated for WNV and DENV [20].
In summary, KFDV infected mice displayed higher morbidity
and mortality than AHFV-infected mice in the C57BL/6J mouse
model. KFDV-infected mice uniformly succumbed to disease 7–9
days post-infection, following a rapid disease progression charac-
terized by high viral loads, significant clinical chemistry abnor-
malities and marked pathology in the gastrointestinal tract and
brain. In contrast, approximately 50% of AHFV-infected died
between 10 and 15 days post-infection, with evidence of delayed
virus replication relative to KFDV-infected mice. The course of
KFDV infection closely resembles the disease seen following
infection with the prototypic tick-borne hemorrhagic flavivirus,
OHFV, whereas AHFV-infected mice displayed less severe clinical
disease more similar to the encephalitic flaviviruses [21,22]. AHFV
and KFDV, along with OHFV, are categorized as BSL-4 viruses
and are on the Select Agent list of potential biothreat agents and
are considered to be the only tick-borne flaviviruses that cause
hemorrhagic manifestations in people. These features emphasize
the importance of a reliable animal model for these severe
pathogens. In the models described here, KFDV and AHFV
infected mice develop disease similar to that seen in humans,
providing an excellent platform for testing promising vaccines,
antivirals and therapeutics.
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